JP2006523191A - 心臓血管障害に関連する分泌ポリペプチド種 - Google Patents

心臓血管障害に関連する分泌ポリペプチド種 Download PDF

Info

Publication number
JP2006523191A
JP2006523191A JP2006505052A JP2006505052A JP2006523191A JP 2006523191 A JP2006523191 A JP 2006523191A JP 2006505052 A JP2006505052 A JP 2006505052A JP 2006505052 A JP2006505052 A JP 2006505052A JP 2006523191 A JP2006523191 A JP 2006523191A
Authority
JP
Japan
Prior art keywords
cpp
amino acid
polypeptide
seq
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006505052A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006523191A5 (enExample
Inventor
ギレーヌ・アルグー−ピュイ
ナッシマ・ベデール
リディ・ブーゲルレ
イザベル・キュサン
イヴ・マエ
アンヌ・ニクネジャ
サミア・ルファ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genova Ltd
Original Assignee
Genova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genova Ltd filed Critical Genova Ltd
Publication of JP2006523191A publication Critical patent/JP2006523191A/ja
Publication of JP2006523191A5 publication Critical patent/JP2006523191A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
JP2006505052A 2003-04-08 2004-04-07 心臓血管障害に関連する分泌ポリペプチド種 Pending JP2006523191A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US46162303P 2003-04-08 2003-04-08
US46155803P 2003-04-08 2003-04-08
US47147903P 2003-05-16 2003-05-16
US47486303P 2003-05-30 2003-05-30
US48414003P 2003-06-30 2003-06-30
PCT/EP2004/003737 WO2004090551A2 (en) 2003-04-08 2004-04-07 Secreted polypeptide species associated with cardiovascular disorders

Publications (2)

Publication Number Publication Date
JP2006523191A true JP2006523191A (ja) 2006-10-12
JP2006523191A5 JP2006523191A5 (enExample) 2007-06-28

Family

ID=33163255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505052A Pending JP2006523191A (ja) 2003-04-08 2004-04-07 心臓血管障害に関連する分泌ポリペプチド種

Country Status (3)

Country Link
EP (1) EP1616194A2 (enExample)
JP (1) JP2006523191A (enExample)
WO (1) WO2004090551A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013076691A (ja) * 2011-09-12 2013-04-25 Taisho Pharmaceutical Co Ltd 疲労バイオマーカー

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007523844A (ja) * 2003-04-25 2007-08-23 ジェノバ・リミテッド 心臓血管障害において減少する分泌ポリペプチド種
FI118265B (fi) * 2004-01-15 2007-09-14 Jurilab Ltd Oy Menetelmä akuutin sydäninfarktin ja sepelvaltimotaudin riskin havaitsemiseksi

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432400B1 (en) * 1997-01-07 2002-08-13 Laboratoire Laphal (Laboratoire De Pharmacologie Appliquee) Specific pancreatic lipase inhibitors and their applications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
US6503540B1 (en) * 1999-03-25 2003-01-07 David E. Reese Cloning and characterization of bves, a novel gene expressed in heart and uses thereof
IL137307A0 (en) * 2000-07-13 2001-07-24 Biopreventive Ltd A rapid non-invasive method for differential acute cardiac disease diagnosis
WO2003023397A1 (en) * 2001-09-12 2003-03-20 National Research Council Of Canada A method for the simultaneous and direct determination of serum cholesterol in high-and low-density lipoproteins using infrared spectroscopy

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432400B1 (en) * 1997-01-07 2002-08-13 Laboratoire Laphal (Laboratoire De Pharmacologie Appliquee) Specific pancreatic lipase inhibitors and their applications

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013076691A (ja) * 2011-09-12 2013-04-25 Taisho Pharmaceutical Co Ltd 疲労バイオマーカー

Also Published As

Publication number Publication date
WO2004090551A3 (en) 2005-01-20
WO2004090551A2 (en) 2004-10-21
EP1616194A2 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
US20070082363A1 (en) Secreted polypeptide species reduced cardiovascular disorders
JP2008500952A (ja) 心臓血管障害で減少する分泌ポリペプチド種
JP2007501605A (ja) 心血管疾患に関連する分泌ポリペプチド種
US20070009955A1 (en) Secreted polypeptide species associated with cardiovascular disorders
JP2005533086A5 (enExample)
JP2007513063A (ja) 心臓血管障害に関連する分泌ポリペプチド種
JP2006526578A (ja) 心臓血管障害で減少する分泌ポリペプチド種
JP2006523191A (ja) 心臓血管障害に関連する分泌ポリペプチド種
US20060148690A1 (en) Secreted peptides
US20070128664A1 (en) Secreted polypeptide species associated with cardiovascular disorders
WO2006029838A2 (en) Secreted polypeptide species involved in alzheimer’s disease
US20070098635A1 (en) Secreted polypeptide species associatedwith cardiovascular disorders
US20070105169A1 (en) Secreted polypeptide species associated with cardiovascular disorders
JP2007527377A (ja) 心臓血管障害で減少される分泌ポリペプチド種
WO2004101615A2 (en) Secreted polypeptide species associated with cardiovascular disorders
JP2006519771A (ja) 心臓血管障害で減少する分泌ポリペプチド種（チトトリオシダーゼ由来のフラグメント）
US20060147447A1 (en) Secreted peptides
WO2006005585A2 (en) Secreted polypeptide species differentially expressed during pregnancy
WO2004005331A2 (en) Peptides derived from pep133 (g1p3, 6-16)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070409

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100209

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100810